Marengo Therapeutics logo

Marengo Therapeutics

A new frontier in the fight against cancer– the right activation of the right immune cells

41 employees · est. 2015 · Cambridge, United States

VS
SURGE Therapeutics logo

SURGE Therapeutics

The intraoperative immunotherapy company

9 employees · est. 2016 · Cambridge, United States

Marengo Therapeutics is the older company (2015 vs 2016); Marengo Therapeutics is the larger of the two.

Side-by-Side Comparison

Marengo Therapeutics SURGE Therapeutics
Founded
2015 older 2016
Headquarters
Cambridge, United States Cambridge, United States
Employees
41 larger 9
Industry
Health Care Biotechnology, Health Care, Life Sciences
Funding Stage
Series B Series B
Total Funding
$80.00M $58.00M
Funding Rounds
2 2
Services
Not tracked yet Development of intraoperative immunotherapy solutions, Manufacture of biodegradable hydrogels for extended drug release
Target Customers
Not tracked yet Cancer patients undergoing surgical tumor resection, Oncologists, Surgical teams specialized in cancer treatment
Taxonomy
Biotech Company, Clinical Stage, Cancer Treatment, Immunotherapy, T Cell Activation, Immune System, Anti-tumor, Therapeutic Platform, Cancer Immunotherapy, Long-term Immunity, Cancer Research, Oncology, Immunology, Biomedical Innovation Cancer Immunotherapy, Intraoperative Treatment, Surgical Intervention, Solid Tumors, Post-surgical Cancer Recurrence, Oncology, Immunotherapy, Cancer Therapy, Patient Survival, Disruptive Technology, Precision Medicine, Medical Innovation
Website
marengotx.com surgetx.com
Marengo Therapeutics logo

About Marengo Therapeutics

Marengo Therapeutics: Marengo Therapeutics, a clinical stage biotech company, is pioneering an entirely new way to activate the body’s own immune system to mount a rapid, effective, and durable response against cancer. Their unique therapeutic platform selectively boosts T cells, turbocharging poten...

SURGE Therapeutics logo

About SURGE Therapeutics

SURGE Therapeutics, founded in 2016, is making waves in the Biotechnology, Health Care, and Life Sciences sectors with their pioneering focus on intraoperative immunotherapy. The company's slogan, "The intraoperative immunotherapy company," highlights their commitment to improving cancer patient su...

We will tell you when either one moves

BounceWatch watches Marengo Therapeutics and SURGE Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Marengo Therapeutics and SURGE Therapeutics — by email.

Frequently Asked Questions

Marengo Therapeutics — A new frontier in the fight against cancer– the right activation of the right immune cells. SURGE Therapeutics — The intraoperative immunotherapy company. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Marengo Therapeutics has raised $80.00M while SURGE Therapeutics has raised $58.00M.
Marengo Therapeutics and SURGE Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Marengo Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Marengo Therapeutics on 9 Jun 2026, and SURGE Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes